Furthermore, because circulating CK-18 levels have been shown to be non-invasive biomarkers for NAFLD/NASH and liver fibrosis prediction [40, 41], knowing whether AAA-1 could elicit fibrosis is under active investigations. This evidence concerns the gene NPSR1-AS1 and metabolic dysfunction-associated steatotic liver disease.